Contraceptives Market Size & Forecast Report, 2012 - 2022

The global Contraceptives Market is estimated to develop at a substantial CAGR for the duration of the prediction. The process of Contraception is thoughtful deterrence of pregnancy by way of interfering with standard procedure of ovulation, insemination, and imbedding by operating methods, medicines, blockades or medicinal devices. Contraceptives also avert gravidity and Sexually Transmitted Diseases [STDs].

The contraceptives industry is estimated to display substantial development for the duration of the prediction. This is credited to growing occurrence of sexually transmitted diseases, technical progressions in feminine contraceptive medications & apparatuses, growing inventiveness by NGOs and governments for the endorsement of contraceptives, and growing alertness among the public. On the other hand, the side effects linked with the usage of contraceptive apparatuses & medications, and increasing occurrence of sterility are controlling the progress of this market.

The Contraceptives market on the source of Type of Delivery Network could span Private Clinic, Self-governing Drug store, Communal, Online Display place, Private, Hospital’s Drugstore, and others. The Contraceptives on the source of Type of End Use could span Ambulatory Clinical Centers, Home-based Care, Private Clinic, Hospitals.

The Contraceptives industry on the source of Type of Product could span Non-Surgical Permanent Contraception Devices, Intrauterine Devices, Contraceptive Sponges, Female Condoms, Male Contraceptive Devices, Topical Contraceptive Patch, Mini-pills, Oral Contraceptives, Sub-dermal Contraceptives Implants, Contraceptive Vaginal Rings, Contraceptive Diaphragms, Female Contraceptive Devices, Contraceptive Devices, Contraceptive Injectable, Combined Contraceptives, Contraceptive Drugs.

The Contraceptives market on the source of Area with respect to Trades in terms of intake, Profits, Market stake and Development percentage in these areas, for the duration of the prediction could span North America [U.S.A, Canada], Europe [France, Spain, Germany, U.K., Italy, Russia], Rest of Europe, Asia Pacific [India, Japan, China, Australia, and New Zealand], Rest of Asia Pacific, Latin America [Mexico, Brazil], Rest of Latin America, Middle East & Africa [GCC nations, South Africa], Rest of Middle East & Africa.

By the source of geography, North America was responsible for the mainstream of the stake of the international market during the past year. The contraceptives industry in North America is estimated to keep up its top position during the course of the prediction owing to growth in alertness among the inhabitants, increase in acceptance of fresh contraceptives, and growth in occurrence of sexually transmitted sicknesses for example HIV/AIDS. The contraceptive market in the U.S.A. books the biggest stake in the market of general contraceptives.

The Europe was an important area for the contraceptives during the past year. The development of this market is mostly owing to stress-free obtainability of contemporary contraceptives and recompense facility for extended period changeable contraceptive action. Asia-Pacific is projected to develop by the rapid step all through the prediction period, due to greater basis of inhabitant’s and active administrative organizations those concentrate on the control of birth.

Furthermore, technical progressions and economical contraceptive merchandises in these areas propose beneficial openings to the producers of contraceptives. Asia Pacific is estimated to be the maximum resourceful area in the contraceptive industry over the prediction period. Owing to robust financial development in the nations like Australia, Philippines, China, Singapore, India and others. The sanction of self-injection contraceptives by the controlling organization of the U.K., has presented it to the nations for example South Africa and additional nations having less earnings.

The statement revises Trades in terms of intake of Contraceptives in the market; particularly in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. It concentrates on the topmost companies operating in these regions. Some of the important companies operating in the field on international level are Pfizer, Inc., Merck & Co., Inc., Cooper Surgical, Inc., Actavis, Inc., Medicines360, Medi safe Distribution Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., Church & Dwight, Co., Inc., Pace Pharmaceuticals Inc., Tewa Pharmaceutical Industries Limited, Bayer HealthCare AG.

Additional companies operating in the field on international level are Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Allergan plc, Merck Co. Inc., Cipla Inc., HLL Life Care Limited, Mankind Pharma. Vardhman Life Care PVT. Ltd., Boehringer Ingelheim GmbH, TTK HealthCare, Agile Therapeutics Inc., Bio Santé Pharmaceuticals Inc., Mayer Laboratories, V-Care Pharma Pvt. Ltd., Watson Pharmaceuticals, Inc., Warner Chilcott Company.

Market Segment:

Global Contraceptives Product Outlook (Revenue, USD Million, 2012 - 2022)
    • Contraceptive Drugs
        • Contraceptive Pills
        • Topical
        • Injectables
    • Contraceptive Devices
        • Male Condoms
        • Female Condoms
        • Vaginal Implants
        • Subdermal Implants
        • Diaphragms
        • Sponges
        • IUDs
            • Copper IUD
            • Hormonal IUD

Contraceptives Regional Outlook (Revenue, USD Million, 2012 - 2022)
    • North America
        • U.S.
        • Canada
    • Europe
        • UK
        • Germany
    • Asia Pacific
        • Japan
        • China
        • India
        • Rest of Asia Pacific
    • Latin America
        • Brazil
        • Rest of Latin America
    • Middle East and Africa
        • South Africa
        • Rest of Middle East and Africa